Circle Pharma
San Francisco
About Circle Pharma
Circle Pharma is an early-stage biotechnology company applying proprietary computational design algorithms and innovative chemistry to develop cell-permeable macrocycle peptide therapeutics against important clinical targets. It does this through an iterative, rational design process that deploys large virtual libraries of conformationally diverse macrocycle scaffolds selected for inherent permeability. The company was founded by Matt Jacobson and Scott Lokey in 2012 and is headed by David J. Earp.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $207.5M
- Funding stage: Late Stage Venture
- Last round: Series D (Sep 2024)
- Website: circlepharma.com
- Phone: 650-392-0363
Industries & Categories
Biotechnology, Clinical Trials, Health Care, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/circle-pharma-113093 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.